HSBC Holdings’s AstraZeneca AZN Stock Holding History

HSBC Holdings’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-30,000	Closed	-$5.52M	–	2910
2025 Q4	$5.52M	Buy	+30,000	New	+$5.26M	﹤0.01%	1165
2020 Q1	–	Sell	-4,550	Closed	-$453K	–	2699
2019 Q4	$453K	Hold	4,550	–	–	﹤0.01%	2277
2019 Q3	$406K	Buy	+4,550	New	+$395K	﹤0.01%	2442
2018 Q3	–	Sell	-60,000	Closed	-$4.21M	–	2537
2018 Q2	$4.21M	Buy	+60,000	New	+$4.32M	0.01%	1194
2013 Q3	–	Sell	-26,851	Closed	-$1.27M	–	1651
2013 Q2	$1.27M	Buy	+26,851	New	+$1.37M	﹤0.01%	1036

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

HSBC Holdings's AZN Position: Q1 2026 in Review

HSBC Holdings reduced its AstraZeneca (AZN) stake by 76% in Q1 2026, selling an estimated $3.92M and leaving 6,297 shares worth $1.23M. The position accounts for ﹤0.01% of the portfolio, ranked #1757.

HSBC Holdings first reported a position in AZN in Q2 2013 and has held it in 52 quarters since. The position peaked at $494M in Q4 2021. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

HSBC Holdings held 6,297 shares of AstraZeneca worth $1.23M as of Q1 2026.
HSBC Holdings sold 20,336 AstraZeneca shares in Q1 2026, an estimated $3.92M.
AstraZeneca made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #1757 holding.
HSBC Holdings first reported a position in AstraZeneca in Q2 2013 and has held it in 52 quarters since.
HSBC Holdings's AstraZeneca position peaked at $494M in Q4 2021.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.